Biosynthesis of the antibiotic nonribosomal peptide penicillin in baker’s yeast

Nature Communications

Volumn 8, Issue , 2017, Pages

  Awan, Ali R ^a   Blount, Benjamin A ^a   Bell, David J ^a   Shaw, William M ^a   Ho, Jack C H ^a   McKiernan, Robert M ^a   Ellis, Tom ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN DERIVATIVE; ANTIINFECTIVE AGENT; PENICILLIN G;

ANTIBIOTICS; ANTIMICROBIAL ACTIVITY; BACTERIUM; BIOACTIVITY; FUNGUS; GENE; GENE EXPRESSION; MOLECULAR ANALYSIS; OPTIMIZATION; PEPTIDE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC BIOSYNTHESIS; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FUNGUS GROWTH; NONHUMAN; NONRIBOSOMAL PEPTIDE SYNTHESIS; PROTEIN ENGINEERING; SACCHAROMYCES CEREVISIAE; STREPTOCOCCUS; BIOSYNTHESIS; ENZYMOLOGY; FERMENTATION; GENETIC ENGINEERING; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYSIOLOGY; PROCEDURES;

FUNGI; SACCHAROMYCES CEREVISIAE; STREPTOCOCCUS;

ANTI-BACTERIAL AGENTS; FERMENTATION; GENETIC ENGINEERING; PENICILLIN G; PENICILLINS; PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT; SACCHAROMYCES CEREVISIAE; STREPTOCOCCUS;

EID: 85039041158     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms15202     Document Type: Article

References (30)

1. Aly, A. H., Debbab, A. & Proksch, P. Fifty years of drug discovery from fungi. Fungal Divers 50, 3–19 (2011).
2. Brakhage, A. A. Regulation of fungal secondary metabolism. Nat. Rev. Microbiol. 11, 21–32 (2013).
3. Kuck, U., Bloemendal, S. & Teichert, I. Putting fungi to work: harvesting a cornucopia of drugs, toxins, and antibiotics. PLoS Pathog. 10, e1003950 (2014).
4. Siddiqui, M. S., Thodey, K., Trenchard, I. & Smolke, C. D. Advancing secondary metabolite biosynthesis in yeast with synthetic biology tools. FEMS Yeast Res. 12, 144–170 (2012).
5. Wattanachaisaereekul, S., Lantz, A. E., Nielsen, M. L. & Nielsen, J. Production of the polyketide 6-MSA in yeast engineered for increased malonyl-CoA supply. Metab. Eng. 10, 246–254 (2008).
6. DeLoache, W. C. et al. An enzyme-coupled biosensor enables (S)-reticuline production in yeast from glucose. Nat. Chem. Biol. 11, 465–471 (2015).
7. Galanie, S., Thodey, K., Trenchard, I. J., Filsinger Interrante, M. & Smolke, C. D. Complete biosynthesis of opioids in yeast. Science 349, 1095–1100 (2015).
8. Ro, D. K. et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440, 940–943 (2006).
9. Krivoruchko, A. & Nielsen, J. Production of natural products through metabolic engineering of Saccharomyces cerevisiae. Curr. Opin. Biotechnol. 35, 7–15 (2015).
10. Felnagle, E. A. et al. Nonribosomal peptide synthetases involved in the production of medically relevant natural products. Mol. Pharm. 5, 191–211 (2008).
11. van den Berg, M. A. et al. Genome sequencing and analysis of the filamentous fungus Penicillium chrysogenum. Nat. Biotechnol. 26, 1161–1168 (2008).
12. Siewers, V., Chen, X., Huang, L., Zhang, J. & Nielsen, J. Heterologous production of non-ribosomal peptide LLD-ACV in Saccharomyces cerevisiae. Metab. Eng. 11, 391–397 (2009).
13. Meijer, W. H. et al. Peroxisomes are required for efficient penicillin biosynthesis in Penicillium chrysogenum. Appl. Environ. Microbiol. 76, 5702–5709 (2010).
14. Gould, S. J., Keller, G. A., Hosken, N., Wilkinson, J. & Subramani, S. A conserved tripeptide sorts proteins to peroxisomes. J. Cell Biol. 108, 1657–1664 (1989).
15. Awan, A. R., Shaw, W. M. & Ellis, T. Biosynthesis of therapeutic natural products using synthetic biology. Adv. Drug Deliv. Rev. 105, 96–106 (2016).
16. Lim, F. Y. & Keller, N. P. Spatial and temporal control of fungal natural product synthesis. Nat. Prod. Rep. 31, 1277–1286 (2014).
17. Lee, M. E., DeLoache, W. C., Cervantes, B. & Dueber, J. E. A highly characterized yeast toolkit for modular, multipart assembly. ACS Synth. Biol. 4, 975–986 (2015).
18. Engler, C., Kandzia, R. & Marillonnet, S. A one pot, one step, precision cloning method with high throughput capability. PLoS ONE 3, e3647 (2008).
19. Ip, C. L. et al. MinION Analysis and Reference Consortium: phase 1 data release and analysis. F1000Res 4, 1075 (2015).
20. Haas, W. et al. Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria. Antimicrob. Agents Chemother. 53, 3552–3560 (2009).
21. Gidijala, L. et al. An engineered yeast efficiently secreting penicillin. PLoS ONE 4, e8317 (2009).
22. Boghigian, B. A., Seth, G., Kiss, R. & Pfeifer, B. A. Metabolic flux analysis and pharmaceutical production. Metab. Eng. 12, 81–95 (2010).
23. Simeonidis, E. & Price, N. D. Genome-scale modeling for metabolic engineering. J. Ind. Microbiol. Biotechnol. 42, 327–338 (2015).
24. Jensen, M. K. & Keasling, J. D. Recent applications of synthetic biology tools for yeast metabolic engineering. FEMS Yeast Res. 15, 1–10 (2015).
25. Caboche, S., Leclere, V., Pupin, M., Kucherov, G. & Jacques, P. Diversity of monomers in nonribosomal peptides: towards the prediction of origin and biological activity. J. Bacteriol. 192 5143–5150 (2010).
26. Walsh, C. T. Polyketide and nonribosomal peptide antibiotics: modularity and versatility. Science 303, 1805–1810 (2004).
27. Winn, M., Fyans, J. K., Zhuo, Y. & Micklefield, J. Recent advances in engineering nonribosomal peptide assembly lines. Nat. Prod. Rep. 33, 317–347 (2016).
28. Weissman, K. J. The structural biology of biosynthetic megaenzymes. Nat. Chem. Biol. 11, 660–670 (2015).
29. Butler, M. S. & Buss, A. D. Natural products—the future scaffolds for novel antibiotics? Biochem. Pharmacol. 71, 919–929 (2006).
30. Loman, N. J. & Quinlan, A. R. Poretools: a toolkit for analyzing nanopore sequence data. Bioinformatics 30, 3399–3401 (2014).